B. Chastek

发表

Health Care Costs Among Individuals With Chronic Obstructive Pulmonary Disease Within Several Large, Multi-State Employers

A. Phillips, T. Darkow, B. Chastek, 2008, Journal of occupational and environmental medicine.

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

Najam Ali Khan, J. Cappelleri, J. Allegretti, 2022, BMC Gastroenterology.

Health care costs for patients with cancer at the end of life.

J. Kallich, L. Newcomer, C. Paoli, 2012, Journal of oncology practice.

Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA

S. Shinde, Wenhui Wei, Chieh-I Chen, 2017, Advances in Therapy.

Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database

M. Paudel, B. Solow, A. Buikema, 2021, EClinicalMedicine.

Development and validation of a one year predictive model for secondary fractures in osteoporosis

J. Cauley, S. Greenspan, B. Chastek, 2021, PloS one.

Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database.

J. Walsh, Yujin Park, B. Chastek, 2018, Journal of comparative effectiveness research.

Impact of Metastatic Colorectal Cancer Stage and Number of Treatment Courses on Patient Health Care Costs and Utilization

B. Seal, S. Valluri, B. Chastek, 2013, Postgraduate medicine.

Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer†

T. Horstman, L. Newcomer, J. Malin, 2020, Cancer investigation.

Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis

J. Curtis, P. Mahajan, L. Becker, 2017, Journal of medical economics.

Treatment Patterns and Disease Burden of Triple Therapy in Asthma

B. Chastek, M. Bogart, K. Sundquist, 2020 .

Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017

J. Curtis, E. Lewiecki, L. Fitzpatrick, 2020, Osteoporosis International.

Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting

Anand A. Dalal, H. Ortega, F. Albers, 2016, Journal of managed care & specialty pharmacy.

Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa

J. Feinstein, B. Chastek, A. Bruckner, 2022, Orphanet Journal of Rare Diseases.

CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING

D. Harrison, S. Gandra, D. Pearson, 2011 .

Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database.

J. Walsh, B. Chastek, P. Hur, 2018, Journal of managed care & specialty pharmacy.

Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan

K. Fox, S. Gandra, B. Chastek, 2012, Advances in Therapy.

Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

K. Fox, G. Kricorian, S. Gandra, 2013, The Journal of dermatological treatment.

Differences in survival for patients with metastatic colorectal cancer by lines of treatment received and stage at original diagnosis

B. Seal, S. Valluri, B. Chastek, 2015, International journal of clinical practice.

Impact of Treatment Complexity on Adherence and Glycemic Control : An Analysis of Oral Antidiabetic Agents

B. Chastek, Janette Moran, M. Pollack, 2022 .

Characteristics of Patients Treated With Vedolizumab for Inflammatory Bowel Disease in the United States: 1835

H. Patel, B. Chastek, R. Mody, 2015 .

Estimating the Incidence and Prevalence of Juvenile-Onset Recurrent Respiratory Papillomatosis in Publicly and Privately Insured Claims Databases in the United States

C. Derkay, B. Chastek, Vinay Mehta, 2014, Sexually transmitted diseases.

Economic burden of osteoporotic fractures in US managed care enrollees.

J. Curtis, B. Chastek, Yamei Wang, 2020, The American journal of managed care.

Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims

M. Lopez-Bresnahan, M. Oleen-Burkey, B. Chastek, 2010, Journal of medical economics.

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

S. Bunner, S. Blank, K. McLaurin, 2022, Advances in Therapy.

Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.

D. Collier, J. Curtis, D. Harrison, 2015, Journal of managed care & specialty pharmacy.

Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURN

M. Vu, B. Chastek, Sabyasachi Ghosh, 2023, BMC Gastroenterology.

Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base.

H. Ortega, C. Bell, B. Chastek, 2020, Allergy and asthma proceedings.

Further evaluation of a claims-based algorithm to determine the effectiveness of biologics for rheumatoid arthritis using commercial claims data

D. Collier, J. Curtis, D. Harrison, 2013, Arthritis Research & Therapy.

Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database

J. Walsh, B. Chastek, P. Hur, 2018, Journal of managed care & specialty pharmacy.

Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population

M. Amonkar, B. Chastek, A. Teitelbaum, 2011, Journal of medical economics.

A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients

B. Chastek, B. Stolshek, Damon Van Voorhis, 2016, Advances in Therapy.

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

S. Palli, B. Chastek, L. Bengtson, 2021, Journal of managed care & specialty pharmacy.

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis

E. Hulbert, B. Chastek, Shirley P Huang, 2023, Cureus.